Investor's Business Daily on MSN2d
Why IBD Stock Of The Day Quest Diagnostics Sidestepped The Sell-OffQuest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling.
This week, Quest Diagnostics made one of those deals. The diagnostics giant announced a new partnership with Google Cloud that aims to deliver new AI capabilities — including predictive ...
(RTTNews) - Quest Diagnostics (DGX) reaffirmed its guidance for full year 2025. The company continues to project: adjusted EPS in a range of $9.55 to $9.80, and net revenues in a range of $10.70 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback